Follow
Brian Danysh
Brian Danysh
Operations Manager, Broad Institute
Verified email at broadinstitute.org
Title
Cited by
Cited by
Year
Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers
AR Parikh, I Leshchiner, L Elagina, L Goyal, C Levovitz, G Siravegna, ...
Nature medicine 25 (9), 1415-1421, 2019
4172019
The lens capsule
BP Danysh, MK Duncan
Experimental eye research 88 (2), 151-164, 2009
3392009
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma
NJ Haradhvala, MB Leick, K Maurer, SH Gohil, RC Larson, N Yao, ...
Nature medicine 28 (9), 1848-1859, 2022
1122022
Parallel genomic alterations of antigen and payload targets mediate polyclonal acquired clinical resistance to sacituzumab govitecan in triple-negative breast cancer
JT Coates, S Sun, I Leshchiner, N Thimmiah, EE Martin, D McLoughlin, ...
Cancer discovery 11 (10), 2436-2445, 2021
882021
Abnormal expression of collagen IV in lens activates unfolded protein response resulting in cataract
Z Firtina, BP Danysh, X Bai, DB Gould, T Kobayashi, MK Duncan
Journal of Biological Chemistry 284 (51), 35872-35884, 2009
872009
BRAF inhibitors: experience in thyroid cancer and general review of toxicity
ME Cabanillas, A Patel, BP Danysh, R Dadu, S Kopetz, G Falchook
Hormones and Cancer 6, 21-36, 2015
722015
Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model
BP Danysh, EY Rieger, DK Sinha, CV Evers, GJ Cote, ME Cabanillas, ...
Oncotarget 7 (21), 30907, 2016
662016
AXL and error-prone DNA replication confer drug resistance and offer strategies to treat EGFR-mutant lung cancer
A Noronha, N Belugali Nataraj, JS Lee, B Zhitomirsky, Y Oren, S Oster, ...
Cancer discovery 12 (11), 2666-2683, 2022
522022
Characterizing molecular diffusion in the lens capsule
BP Danysh, TP Patel, KJ Czymmek, DA Edwards, L Wang, J Pande, ...
Matrix Biology 29 (3), 228-236, 2010
482010
Improved cellular specificity of plasmonic nanobubbles versus nanoparticles in heterogeneous cell systems
EY Lukianova-Hleb, X Ren, PE Constantinou, BP Danysh, DL Shenefelt, ...
Plos one 7 (4), e34537, 2012
472012
Src-mediated regulation of the PI3K pathway in advanced papillary and anaplastic thyroid cancer
TC Beadnell, KW Nassar, MM Rose, EG Clark, BP Danysh, MC Hofmann, ...
Oncogenesis 7 (2), 23, 2018
462018
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome
EM Parry, I Leshchiner, R Guièze, C Johnson, E Tausch, SA Parikh, ...
Nature medicine 29 (1), 158-169, 2023
402023
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance
A Naeem, F Utro, Q Wang, J Cha, M Vihinen, S Martindale, Y Zhou, Y Ren, ...
Blood advances 7 (9), 1929-1943, 2023
372023
The transcription factor ETV5 mediates BRAFV600E-induced proliferation and TWIST1 expression in papillary thyroid cancer cells
OR Puli, BP Danysh, E McBeath, DK Sinha, NM Hoang, RT Powell, ...
Neoplasia 20 (11), 1121-1134, 2018
352018
Contributions of mouse genetic background and age on anterior lens capsule thickness
BP Danysh, KJ Czymmek, PT Olurin, JG Sivak, MK Duncan
The Anatomical Record: Advances in Integrative Anatomy and Evolutionary …, 2008
352008
Transmembrane mucins as novel therapeutic targets
PE Constantinou, BP Danysh, N Dharmaraj, DD Carson
Expert review of endocrinology & metabolism 6 (6), 835-848, 2011
332011
Ponatinib activates an inflammatory response in endothelial cells via ERK5 SUMOylation
J Paez-Mayorga, AL Chen, S Kotla, Y Tao, RJ Abe, ED He, BP Danysh, ...
Frontiers in cardiovascular medicine 5, 125, 2018
272018
Parallel genomic alterations of antigen and payload targets mediate polyclonal acquired clinical resistance to sacituzumab govitecan in triple-negative breast cancer. Cancer …
JT Coates, S Sun, I Leshchiner, N Thimmiah, EE Martin, D McLoughlin, ...
DOI: https://doi. org/10.1158/2159-8290. CD-21-0702, 2436-2445, 0
21
RAC1 Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient
R Bagheri-Yarmand, NL Busaidy, E McBeath, BP Danysh, KW Evans, ...
Cancers 13 (19), 4950, 2021
202021
The MUC1 ectodomain: a novel and efficient target for gold nanoparticle clustering and vapor nanobubble generation
BP Danysh, PE Constantinou, EY Lukianova-Hleb, DO Lapotko, ...
Theranostics 2 (8), 777, 2012
202012
The system can't perform the operation now. Try again later.
Articles 1–20